Related Experiment Video
Updated: Jan 25, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Identification of Kinases Responsible for p53-Dependent Autophagy
Stephanie L Celano1, Lisette P Yco2, Matthew G Kortus3
1College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, USA; Center for Cancer Cell Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Abstract:
In cancer, autophagy is upregulated to promote cell survival and tumor growth during times of nutrient stress and can confer resistance to drug treatments. Several major signaling networks control autophagy induction, including the p53 tumor suppressor pathway. In response to DNA damage and other cellular stresses, p53 is stabilized and activated, while HDM2 binds to and ubiquitinates p53 for proteasome degradation. Thus blocking the HDM2-p53 interaction is a promising therapeutic strategy in cancer; however, the potential survival advantage conferred by autophagy induction may limit therapeutic efficacy. In this study, we leveraged an HDM2 inhibitor to identify kinases required for p53-dependent autophagy. Interestingly, we discovered that p53-dependent autophagy requires several kinases, including the myotonic dystrophy protein kinase-like alpha (MRCKα). MRCKα is a CDC42 effector reported to activate actin-myosin cytoskeletal reorganization. Overall, this study provides evidence linking MRCKα to autophagy and reveals additional insights into the role of kinases in p53-dependent autophagy.
Insights
Blocking the HDM2-p53 interaction is a cancer therapy strategy. This study found that myotonic dystrophy protein kinase-like alpha (MRCKα) is crucial for p53-dependent autophagy, a process that aids cancer cell survival.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Cellular Stress Response
Background:
- Autophagy promotes cancer cell survival and drug resistance, often upregulated during nutrient stress.
- The p53 tumor suppressor pathway is a key regulator of autophagy induction.
- Inhibiting the HDM2-p53 interaction is a therapeutic strategy, but autophagy may limit efficacy.
Purpose of the Study:
- To identify kinases involved in p53-dependent autophagy using an HDM2 inhibitor.
- To elucidate the role of specific kinases in the p53-autophagy axis in cancer.
Main Methods:
- Utilized an HDM2 inhibitor to probe p53-dependent autophagy pathways.
- Investigated the requirement of various kinases, including MRCKα, in p53-mediated autophagy.
- Characterized the function of identified kinases in the context of cancer cell survival.
Main Results:
- Discovered that p53-dependent autophagy requires several kinases.
- Identified myotonic dystrophy protein kinase-like alpha (MRCKα) as a key kinase in this pathway.
- MRCKα, a known CDC42 effector, was linked to actin-myosin cytoskeletal regulation in autophagy.
Conclusions:
- MRCKα plays a significant role in p53-dependent autophagy.
- This study reveals a novel link between MRCKα and autophagy.
- Provides insights into the kinase-mediated regulation of p53-dependent autophagy in cancer.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Receptor Tyrosine Kinases
Frequency-dependent Selection

